Por: Associated Press Business February 15, 2023
NEWTON, Mass. (AP) — NEWTON, Mass. (AP) — Karyopharm Therapeutics Inc. (KPTI) on Wednesday reported a fourth-quarter loss of $38.5 million, after reporting a profit in the same period a year earlier.On a per-share basis, the Newton, Massachusetts-based company said it had a loss of 43 cents.The results did not meet Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 34... + full article
MarketWatch USA Business July 08, 2023
Masimo stock has risen about 7% year to date through the close on July 6. Decreases in Holdings (VERA) (ticker: CG) cut its position in the pharmaceutical company to 2,416,837 shares. Carlyle subsidiary Abingworth Bioventures 8 LP sold 543,394 Vera Therapeutics shares at... + más
Lawsuit accuses medical tech company Masimo of creating an Apple Watch clone | 9to5Mac
Masimo Apple Watch clone was based on access to confidential info and source code | 9to5Mac
MarketWatch USA Business June 21, 2023
The XBI is still down roughly 50% from its high in February 2021, but things in the sector are looking better than they have in a while. In an effort to find opportunities, Barron’s screened the XBI and another biotech ETF, the (IBB), for the stocks with a market value of more... + más
US health system will go 'bankrupt' in 'a few years,' biotech entrepreneur warns | Fox Business
Daydream Believers: Read This Before You Invest In AI | Forbes
MarketWatch USA Business April 08, 2023
325 Capital entered into a cooperation agreement with the company on March 20 that led to the appointment of 325 Capital managing partner Michael Braner to American Public’s board on March 28. As a result, 235 Capital received a grant of 2,405 restricted shares, which are... + más
‘Chucky’ star Jennifer Tilly explains why she enjoys filming sex scenes: ‘It’s an out-of-body experience’ | Fox News
Portland receives more than 60 applicants for open city manager job | Portland Press Herald
RTTNews USA Health January 18, 2023
This commercial-stage biotechnology company developing next-generation, targeted antibody drug conjugates is aiming to achieve double-digit year-over-year revenue growth for its lead drug.The company we are profiling today is ADC Therapeutics SA () and the drug in focus is... + más
Nkarta | RTTNews
Chicago White Sox pitcher Liam Hendriks says he will undergo cancer treatment after being diagnosed with non-Hodgkin's lymphoma | CBS News
WPTV USA Nation November 30, 2022
If you or someone you love deals with a chronic disease, you're likely aware of injections. New research is indicating that in the not-too-distant future, that same medication and routine vaccinations might come in a pill form.For 10 years, biotech company has been working... + más
Op-Ed: Fentanyl pill producers used to mimic other pharmaceuticals, now they don't have to | Los Angeles Times
Hey FDA, Free the Birth Control Pill! | The Daily Beast
RTTNews USA Health November 29, 2022
Biopharmaceutical company Aclaris Therapeutics, Inc. () and Chinese therapeutic company Pediatrix Therapeutics, Inc. announced that the companies have entered into a license agreement.Under the license agreement, Aclaris has granted Pediatrix the exclusive rights to develop,... + más
Visconti: Pens And Inks For Fall | Forbes
Subscribe to HP Instant Ink and save $100s per year on ink | New York Post
The Boston Globe USA Business October 12, 2022
Competition is heating up among biotech startups building technologies that improve or expand upon what gene editing can do. While most of these firms are devising therapies that permanently modify DNA to treat, and potentially cure, genetic diseases, a growing number think that... + más
Tech insiders have a lot to say about the local startup scene. Most of it is good. | The Boston Globe
See the presentations that hot healthcare startups used to raise millions from top VCs | Business Insider
About iurex | Privacy Policy | Disclaimer |